Permitting patients to pay for participation in clinical trials: the advent of the P4 trial.
Med Health Care Philos
; 20(2): 219-227, 2017 Jun.
Article
em En
| MEDLINE
| ID: mdl-27757784
ABSTRACT
In this article we explore the ethical issues raised by permitting patients to pay for participation (P4) in clinical trials, and discuss whether there are any categorical objections to this practice. We address key considerations concerning payment for participation in trials, including patient autonomy, risk/benefit and justice, taking account of two previous critiques of the ethics of P4. We conclude that such trials could be ethical under certain strict conditions, but only if other potential sources of funding have first been explored or are unavailable.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Participação do Paciente
/
Pesquisa Biomédica
Tipo de estudo:
Etiology_studies
/
Risk_factors_studies
Limite:
Humans
Idioma:
En
Revista:
Med Health Care Philos
Assunto da revista:
ETICA
Ano de publicação:
2017
Tipo de documento:
Article
País de afiliação:
Holanda